Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
C Cordonnier, S Einarsdottir, S Cesaro… - The Lancet infectious …, 2019 - thelancet.com
Infection is a main concern after haemopoietic stem cell transplantation (HSCT) and a major
cause of transplant-related mortality. Some of these infections are preventable by …
cause of transplant-related mortality. Some of these infections are preventable by …
Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience
SM Garland, SK Kjaer, N Muñoz… - Reviews of Infectious …, 2016 - academic.oup.com
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public
health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) …
health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) …
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
causally linked with the development of cervical precancer and cancer. HPV types 16 and …
[HTML][HTML] Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women …
SK Kjaer, M Nygård, K Sundström, J Dillner… - …, 2020 - thelancet.com
Background The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …
A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries
SK Kjaer, M Nygård, J Dillner… - Clinical Infectious …, 2018 - academic.oup.com
Background The long-term effectiveness of the quadrivalent human papillomavirus (qHPV)
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …
Safety of human papillomavirus vaccines: an updated review
A Phillips, C Patel, A Pillsbury, J Brotherton… - Drug safety, 2018 - Springer
Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …
countries. Unfortunately, uptake has been impacted in some countries by reduced …
[HTML][HTML] Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe
S Hartwig, JL St Guily, G Dominiak-Felden… - Infectious agents and …, 2017 - Springer
Background In addition to cervical cancer, human papillomavirus (HPV) is responsible for a
significant proportion of cancers and precancerous lesions of the vulva, vagina, anus, penis …
significant proportion of cancers and precancerous lesions of the vulva, vagina, anus, penis …
[PDF][PDF] Human papilloma virus in oral cancer
SM Kim - Journal of the Korean Association of Oral and …, 2016 - synapse.koreamed.org
Cervical cancer is the second most prevalent cancer among women, and it arises from cells
that originate in the cervix uteri. Among several causes of cervical malignancies, infection …
that originate in the cervix uteri. Among several causes of cervical malignancies, infection …
Safety profile of the 9-valent HPV vaccine: a combined analysis of 7 phase III clinical trials
ED Moreira, SL Block, D Ferris, AR Giuliano… - …, 2016 - publications.aap.org
OBJECTIVES: The overall safety profile of the 9-valent human papillomavirus (9vHPV)
vaccine was evaluated across 7 Phase III studies, conducted in males and females …
vaccine was evaluated across 7 Phase III studies, conducted in males and females …
Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage
JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …